{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:42:14Z","timestamp":1761730934237,"version":"build-2065373602"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Veterinary Cardiology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.jvc.2021.06.001","type":"journal-article","created":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T20:27:04Z","timestamp":1624652824000},"page":"84-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Prospective clinical trial evaluating spironolactone in Doberman pinschers with congestive heart failure due to dilated cardiomyopathy"],"prefix":"10.1016","volume":"40","author":[{"given":"A.","family":"Laskary","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Fonfara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2963-3325","authenticated-orcid":false,"given":"H.","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8524-5749","authenticated-orcid":false,"given":"M.L.","family":"O'Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvc.2021.06.001_bib1","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","volume":"113","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jvc.2021.06.001_bib2","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1939-1676.2010.0479.x","article-title":"Prevalence of dilated cardiomyopathy in Doberman Pinschers in various age groups","volume":"24","author":"Wess","year":"2010","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2021.06.001_bib3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1939-1676.2011.0695.x","article-title":"Mortality in North American dogs from 1984 to 2004: an investigation into age-, size-, and breed-related causes of death","volume":"25","author":"Fleming","year":"2011","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2021.06.001_bib4","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2460\/javma.1997.210.04.505","article-title":"Clinical and pathologic findings in Doberman pinschers with occult cardiomyopathy that died suddenly or developed congestive heart failure: 54 cases (1984-1991)","volume":"210","author":"Calvert","year":"1997","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.jvc.2021.06.001_bib5","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1939-1676.2008.0116.x","article-title":"Effect of pimobendan on case fatality rate in Doberman Pinschers with congestive heart failure caused by dilated cardiomyopathy","volume":"22","author":"O'Grady","year":"2008","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2021.06.001_bib6","first-page":"255","article-title":"A double-blind, randomized, placebo-controlled study of pimobendan in dogs with dilated cardiomyopathy","volume":"16","author":"Fuentes","year":"2002","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2021.06.001_bib7","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1939-1676.1995.tb01074.x","article-title":"Acute and short-term hemodynamic, echocardiographic, and clinical effects of enalapril maleate in dogs with naturally acquired heart failure: results of the Invasive Multicenter PROspective Veterinary Evaluation of Enalapril study","volume":"9","year":"1995","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2021.06.001_bib8","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2460\/javma.1998.213.11.1573","article-title":"Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group","volume":"213","author":"Ettinger","year":"1998","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.jvc.2021.06.001_bib9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1760-2734(06)70025-X","article-title":"The effect of benazepril on survival times and clinical signs of dogs with congestive heart failure: results of a multicenter, prospective, randomized, double-blinded, placebo-controlled, long-term clinical trial","volume":"1","year":"1999","journal-title":"J Vet Cardiol"},{"key":"10.1016\/j.jvc.2021.06.001_bib10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1939-1676.1995.tb01075.x","article-title":"Controlled clinical evaluation of enalapril in dogs with heart failure: results of the Cooperative Veterinary Enalapril Study Group","volume":"9","year":"1995","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2021.06.001_bib11","first-page":"171","article-title":"The neuroendocrinology of congestive heart failure","volume":"13","author":"Opie","year":"2002","journal-title":"Cardiovasc J South Afr"},{"key":"10.1016\/j.jvc.2021.06.001_bib12","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1172\/JCI108431","article-title":"The renin-angiotensin-aldosterone system in congestive failure in conscious dogs","volume":"57","author":"Watkins","year":"1976","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jvc.2021.06.001_bib13","first-page":"107","article-title":"Myocardial fibrosis: role of angiotensin II and aldosterone","volume":"88","author":"Weber","year":"1993","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jvc.2021.06.001_bib14","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/jvim.15454","article-title":"The renin-angiotensin-aldosterone system and its suppression","volume":"33","author":"Ames","year":"2019","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2021.06.001_bib15","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.102.22.2700","article-title":"Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators","volume":"102","author":"Zannad","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jvc.2021.06.001_bib16","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1161\/01.CIR.82.5.1730","article-title":"Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group","volume":"82","author":"Swedberg","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.jvc.2021.06.001_bib17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.tvjl.2010.04.016","article-title":"Associations between cardiac pathology and clinical, echocardiographic and electrocardiographic findings in dogs with chronic congestive heart failure","volume":"185","author":"Falk","year":"2010","journal-title":"Vet J"},{"key":"10.1016\/j.jvc.2021.06.001_bib18","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","author":"Yusuf","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvc.2021.06.001_bib19","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure. Results of the cooperative north scandinavian enalapril survival study (CONSENSUS)","volume":"316","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvc.2021.06.001_bib20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF00877755","article-title":"\"Escape\" of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: implications for therapy","volume":"9","author":"Pitt","year":"1995","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jvc.2021.06.001_bib21","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1111\/jvim.15863","article-title":"Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: the VALVE trial","volume":"34","author":"Wess","year":"2020","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2021.06.001_bib22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/eurheartj\/16.suppl_N.107","article-title":"ACE inhibitor co-therapy in patients with heart failure: rationale for the Randomized Aldactone Evaluation Study (RALES)","volume":"16","author":"Pitt","year":"1995","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvc.2021.06.001_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvc.2021.06.001_bib24","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2460\/ajvr.1996.57.11.1645","article-title":"Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation","volume":"57","author":"Haggstrom","year":"1996","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.jvc.2021.06.001_bib25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/jvp.12154","article-title":"Aldosterone breakthrough with benazepril in furosemide-activated renin-angiotensin-aldosterone system in normal dogs","volume":"38","author":"Lantis","year":"2015","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1016\/j.jvc.2021.06.001_bib26","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jvc.2017.03.001","article-title":"Aldosterone breakthrough in dogs with naturally occurring myxomatous mitral valve disease","volume":"19","author":"Ames","year":"2017","journal-title":"J Vet Cardiol"},{"key":"10.1016\/j.jvc.2021.06.001_bib27","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvc.2021.06.001_bib28","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1939-1676.2009.0467.x","article-title":"Efficacy of spironolactone on survival in dogs with naturally occurring mitral regurgitation caused by myxomatous mitral valve disease","volume":"24","author":"Bernay","year":"2010","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2021.06.001_bib29","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1365-2885.2010.01235.x","article-title":"Lack of efficacy of low-dose spironolactone as adjunct treatment to conventional congestive heart failure treatment in dogs","volume":"34","author":"Schuller","year":"2011","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1016\/j.jvc.2021.06.001_bib30","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1939-1676.2009.0346.x","article-title":"Efficacy of benazepril hydrochloride to delay the progression of occult dilated cardiomyopathy in Doberman Pinschers","volume":"23","author":"O'Grady","year":"2009","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2021.06.001_bib31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1939-1676.1993.tb01015.x","article-title":"Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat. Echocardiography committee of the specialty of cardiology, American College of veterinary internal medicine","volume":"7","author":"Thomas","year":"1993","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2021.06.001_bib32","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/0300985820906895","article-title":"Canine dilated cardiomyopathy: diffuse remodeling, focal lesions, and the involvement of macrophages and new vessel formation","volume":"57","author":"Gasparini","year":"2020","journal-title":"Vet Pathol"},{"key":"10.1016\/j.jvc.2021.06.001_bib33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1354\/vp.36-3-221","article-title":"Dilated cardiomyopathy of Doberman pinschers: retrospective histomorphologic evaluation of heart from 32 cases","volume":"36","author":"Everett","year":"1999","journal-title":"Vet Pathol"},{"key":"10.1016\/j.jvc.2021.06.001_bib34","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1161\/01.CIR.0000039104.56479.42","article-title":"Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure","volume":"106","author":"Suzuki","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jvc.2021.06.001_bib35","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/jce.12115","article-title":"Spironolactone improves the arrhythmogenic substrate in heart failure by preventing ventricular electrical activation delays associated with myocardial interstitial fibrosis and inflammation","volume":"24","author":"Esposito","year":"2013","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jvc.2021.06.001_bib36","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jvc.2019.12.002","article-title":"DELay of appearance of sYmptoms of canine degenerative mitral valve disease treated with spironolactone and benazepril: the DELAY study","volume":"27","author":"Borgarelli","year":"2020","journal-title":"J Vet Cardiol"},{"key":"10.1016\/j.jvc.2021.06.001_bib37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13023-017-0590-8","article-title":"Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: results of a two-year open-label extension trial","volume":"12","author":"Raman","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jvc.2021.06.001_bib38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jvc.2007.10.002","article-title":"Effect of spironolactone on diuresis and urine sodium and potassium excretion in healthy dogs","volume":"9","author":"Jeunesse","year":"2007","journal-title":"J Vet Cardiol"},{"key":"10.1016\/j.jvc.2021.06.001_bib39","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1365-2885.2009.01130.x","article-title":"A preclinical pharmacokinetic and pharmacodynamic approach to determine a dose of spironolactone for treatment of congestive heart failure in dog","volume":"33","author":"Guyonnet","year":"2010","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1016\/j.jvc.2021.06.001_bib40","doi-asserted-by":"crossref","first-page":"105535","DOI":"10.1016\/j.tvjl.2020.105535","article-title":"The role of atrial fibrillation as a prognostic factor in doberman pinschers with dilated cardiomyopathy and congestive heart failure","volume":"264","author":"Friederich","year":"2020","journal-title":"Vet J"},{"key":"10.1016\/j.jvc.2021.06.001_bib41","doi-asserted-by":"crossref","first-page":"223","DOI":"10.5603\/CJ.2012.0043","article-title":"Antiarrhythmic potential of aldosterone antagonists in atrial fibrillation","volume":"19","author":"D\u0105browski","year":"2012","journal-title":"Cardiol J"},{"key":"10.1016\/j.jvc.2021.06.001_bib42","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jacc.2007.09.064","article-title":"Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation","volume":"51","author":"Burstein","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvc.2021.06.001_bib43","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1111\/j.1476-5381.2009.00551.x","article-title":"Effects of spironolactone on atrial structural remodelling in a canine model of atrial fibrillation produced by prolonged atrial pacing","volume":"159","author":"Zhao","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jvc.2021.06.001_bib44","first-page":"626","article-title":"Effects of perindopril and spirolactone on plasma aldosterone and left atrial remodeling in a canine model of atrial fibrillation","volume":"37","author":"Luo","year":"2009","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"10.1016\/j.jvc.2021.06.001_bib45","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00029330-200801010-00008","article-title":"Effects of spironolactone on electrical and structural remodeling of atrium in congestive heart failure dogs","volume":"121","author":"Yang","year":"2008","journal-title":"Chin Med J"},{"key":"10.1016\/j.jvc.2021.06.001_bib46","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.ijcard.2015.05.167","article-title":"Spironolactone is associated with reduced risk of new-onset atrial fibrillation in patients receiving renal replacement therapy","volume":"202","author":"Chung","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jvc.2021.06.001_bib47","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijcard.2016.12.029","article-title":"Aldosterone pathway blockade to prevent atrial fibrillation: a systematic review and meta-analysis","volume":"231","author":"Neefs","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jvc.2021.06.001_bib48","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/europace\/euv366","article-title":"Mineralocorticoid receptor antagonists and atrial fibrillation: a meta-analysis","volume":"18","author":"Liu","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.jvc.2021.06.001_bib49","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.tvjl.2014.09.004","article-title":"The influence of enalapril and spironolactone on electrolyte concentrations in Doberman pinschers with dilated cardiomyopathy","volume":"202","author":"Thomason","year":"2014","journal-title":"Vet J"},{"key":"10.1016\/j.jvc.2021.06.001_bib50","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/jvim.12141","article-title":"Safety of spironolactone in dogs with chronic heart failure because of degenerative valvular disease: a population-based, longitudinal study","volume":"27","author":"Lefebvre","year":"2013","journal-title":"J Vet Intern Med"}],"container-title":["Journal of Veterinary Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1760273421000771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1760273421000771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T02:39:21Z","timestamp":1761705561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1760273421000771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":50,"alternative-id":["S1760273421000771"],"URL":"https:\/\/doi.org\/10.1016\/j.jvc.2021.06.001","relation":{},"ISSN":["1760-2734"],"issn-type":[{"type":"print","value":"1760-2734"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective clinical trial evaluating spironolactone in Doberman pinschers with congestive heart failure due to dilated cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Veterinary Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvc.2021.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}